首页 > 最新文献

Asian Journal of Neurosurgery最新文献

英文 中文
Delayed Wound Healing Resulting from Inflammatory Process in Craniectomy Patients Treated with BioGlue: A Case Series with Literature Review 使用 BioGlue 治疗颅骨切除术患者的炎症过程导致伤口延迟愈合:病例系列与文献综述
Pub Date : 2024-06-07 DOI: 10.1055/s-0044-1787673
Methee Wongsirsiuwan
Abstract Background  BioGlue is touted as a safe and effective sealant for various surgical procedures. This article describes five cases of delayed wound healing associated with the use of BioGlue after craniectomies. Case Description  Five patients of different genders and ages who had undergone craniectomy with BioGlue were presented to our medical center with wound dehiscence and purulent discharge. The first attempt to solve this problem by incision and drainage was unsuccessful. The removal of BioGlue is necessary to eliminate these problems. Discussion  The presence of wound dehiscence and aseptic cystic contents may indicate a chronic inflammatory process following the application of BioGlue. This problem usually occurs within a few months after wound closure. For rapid intervention, it is recommended to perform an incision and drainage and remove the BioGlue. The main risk factor is directly applying BioGlue to the skin, subcutaneous tissue, or titanium material. Conclusion  Neurosurgeons should exercise caution and be aware of a possible delayed chronic inflammatory process in surgical wounds associated with the use of BioGlue as a sealant, especially when the product is used without cranial coverage or in cases where it comes into direct contact with subcutaneous tissue or titanium material. To resolve this issue quickly, BioGlue should be completely removed at the first attempt at incision and drainage.
摘要 背景 BioGlue 被誉为用于各种外科手术的安全有效的密封剂。本文描述了五例与颅骨切除术后使用 BioGlue 相关的伤口延迟愈合病例。病例描述 五名不同性别和年龄的患者在接受了使用 BioGlue 的颅骨切除术后,因伤口开裂和脓性分泌物而来到我们的医疗中心。首次尝试通过切开引流解决这一问题,但未获成功。要解决这些问题,必须去除 BioGlue。讨论 伤口开裂和无菌囊性内容物的出现可能表明使用 BioGlue 后出现了慢性炎症过程。这种问题通常发生在伤口闭合后的几个月内。为了快速干预,建议进行切开引流并取出 BioGlue。主要的风险因素是直接将 BioGlue 涂在皮肤、皮下组织或钛材料上。结论 神经外科医生在使用 BioGlue 作为密封剂时,尤其是在未覆盖颅骨或直接接触皮下组织或钛材料的情况下使用该产品时,应谨慎行事并注意手术伤口可能出现的延迟性慢性炎症过程。为尽快解决这一问题,应在首次尝试切开引流时完全清除 BioGlue。
{"title":"Delayed Wound Healing Resulting from Inflammatory Process in Craniectomy Patients Treated with BioGlue: A Case Series with Literature Review","authors":"Methee Wongsirsiuwan","doi":"10.1055/s-0044-1787673","DOIUrl":"https://doi.org/10.1055/s-0044-1787673","url":null,"abstract":"Abstract Background  BioGlue is touted as a safe and effective sealant for various surgical procedures. This article describes five cases of delayed wound healing associated with the use of BioGlue after craniectomies. Case Description  Five patients of different genders and ages who had undergone craniectomy with BioGlue were presented to our medical center with wound dehiscence and purulent discharge. The first attempt to solve this problem by incision and drainage was unsuccessful. The removal of BioGlue is necessary to eliminate these problems. Discussion  The presence of wound dehiscence and aseptic cystic contents may indicate a chronic inflammatory process following the application of BioGlue. This problem usually occurs within a few months after wound closure. For rapid intervention, it is recommended to perform an incision and drainage and remove the BioGlue. The main risk factor is directly applying BioGlue to the skin, subcutaneous tissue, or titanium material. Conclusion  Neurosurgeons should exercise caution and be aware of a possible delayed chronic inflammatory process in surgical wounds associated with the use of BioGlue as a sealant, especially when the product is used without cranial coverage or in cases where it comes into direct contact with subcutaneous tissue or titanium material. To resolve this issue quickly, BioGlue should be completely removed at the first attempt at incision and drainage.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141371065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atherosclerosis-Like Spontaneous Middle Cerebral Artery Dissection 动脉粥样硬化样自发性大脑中动脉夹层
Pub Date : 2024-06-07 DOI: 10.1055/s-0044-1787534
Yodkhwan Wattanasen, S. Komonchan
Abstract The standard of care for treating acute large vessel occlusion is endovascular therapy. The most frequent cause of occlusion is either embolic occlusion or in situ thrombotic occlusion. However, occlusion resulting from intracranial dissection is extremely rare, especially in the middle cerebral artery. Prior to a thrombectomy or endovascular therapy, understanding and interpreting the angiographic findings is crucial for planning the appropriate treatment and preventing complications.
摘要 治疗急性大血管闭塞的标准方法是血管内治疗。最常见的闭塞原因是栓塞或原位血栓闭塞。然而,颅内夹层导致的闭塞极为罕见,尤其是在大脑中动脉。在进行血栓切除术或血管内治疗之前,了解和解释血管造影结果对于制定适当的治疗计划和预防并发症至关重要。
{"title":"Atherosclerosis-Like Spontaneous Middle Cerebral Artery Dissection","authors":"Yodkhwan Wattanasen, S. Komonchan","doi":"10.1055/s-0044-1787534","DOIUrl":"https://doi.org/10.1055/s-0044-1787534","url":null,"abstract":"Abstract The standard of care for treating acute large vessel occlusion is endovascular therapy. The most frequent cause of occlusion is either embolic occlusion or in situ thrombotic occlusion. However, occlusion resulting from intracranial dissection is extremely rare, especially in the middle cerebral artery. Prior to a thrombectomy or endovascular therapy, understanding and interpreting the angiographic findings is crucial for planning the appropriate treatment and preventing complications.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141375405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors for the Differentiation between Glioblastoma, Primary Central Nervous System Lymphoma, and Metastasis in Patients with a Solitary Enhancing Intracranial Mass 颅内单发增大肿块患者区分胶质母细胞瘤、原发性中枢神经系统淋巴瘤和转移瘤的预测因素
Pub Date : 2024-06-06 DOI: 10.1055/s-0044-1787051
Pornthida Chuthip, B. Sitthinamsuwan, Theerapol Witthiwej, Chottiwat Tansirisithikul, Inthira Khumpalikit, S. Nunta-aree
Abstract Introduction  Differentiation between glioblastoma (GBM), primary central nervous system lymphoma (PCNSL), and metastasis is important in decision-making before surgery. However, these malignant brain tumors have overlapping features. This study aimed to identify predictors differentiating between GBM, PCNSL, and metastasis. Materials and Methods  Patients with a solitary intracranial enhancing tumor and a histopathological diagnosis of GBM, PCNSL, or metastasis were investigated. All patients with intracranial lymphoma had PCNSL without extracranial involvement. Demographic, clinical, and radiographic data were analyzed to determine their associations with the tumor types. Results  The predictors associated with GBM were functional impairment ( p  = 0.001), large tumor size ( p  < 0.001), irregular tumor margin ( p  < 0.001), heterogeneous contrast enhancement ( p  < 0.001), central necrosis ( p  < 0.001), intratumoral hemorrhage ( p  = 0.018), abnormal flow void ( p  < 0.001), and hypodensity component on noncontrast cranial computed tomography (CT) scan ( p  < 0.001). The predictors associated with PCNSL comprised functional impairment ( p  = 0.005), deep-seated tumor location ( p  = 0.006), homogeneous contrast enhancement ( p  < 0.001), absence of cystic appearance ( p  = 0.008), presence of hypointensity component on precontrast cranial T1-weighted magnetic resonance imaging (MRI; p  = 0.027), and presence of isodensity component on noncontrast cranial CT ( p  < 0.008). Finally, the predictors for metastasis were an infratentorial ( p  < 0.001) or extra-axial tumor location ( p  = 0.035), smooth tumor margin ( p  < 0.001), and presence of isointensity component on cranial fluid-attenuated inversion recovery MRI ( p  = 0.047). Conclusion  These predictors may be used to differentiate between GBM, PCNSL, and metastasis, and they are useful in clinical management.
摘要 引言 区分胶质母细胞瘤(GBM)、原发性中枢神经系统淋巴瘤(PCNSL)和转移瘤对于手术前的决策非常重要。然而,这些恶性脑肿瘤具有重叠的特征。本研究旨在找出区分 GBM、PCNSL 和转移瘤的预测因子。材料和方法 研究对象为颅内单发增强肿瘤且组织病理学诊断为 GBM、PCNSL 或转移瘤的患者。所有颅内淋巴瘤患者均患有 PCNSL,且未累及颅外。对人口统计学、临床和放射学数据进行了分析,以确定它们与肿瘤类型的关联。结果 与 GBM 相关的预测因素有功能障碍(P = 0.001)、肿瘤体积大(P < 0.001)、肿瘤边缘不规则(P < 0.001)、异质对比增强(P < 0.001)、中心坏死(p < 0.001)、瘤内出血(p = 0.018)、异常血流空洞(p < 0.001)和非对比颅脑计算机断层扫描(CT)低密度成分(p < 0.001)。与 PCNSL 相关的预测因素包括功能障碍(p = 0.005)、深部肿瘤位置(p = 0.006)、均匀对比增强(p < 0.001)、无囊性外观(p = 0.008)、对比前头颅 T1 加权磁共振成像(MRI;p = 0.027)中存在低密度成分以及非对比头颅 CT 中存在等密度成分(p < 0.008)。最后,预测肿瘤转移的因素包括:肿瘤位于幕下(p < 0.001)或轴外(p = 0.035)、肿瘤边缘光滑(p < 0.001)以及头颅液相减影反转恢复磁共振成像出现等密度成分(p = 0.047)。结论 这些预测指标可用于区分 GBM、PCNSL 和转移瘤,并有助于临床治疗。
{"title":"Predictors for the Differentiation between Glioblastoma, Primary Central Nervous System Lymphoma, and Metastasis in Patients with a Solitary Enhancing Intracranial Mass","authors":"Pornthida Chuthip, B. Sitthinamsuwan, Theerapol Witthiwej, Chottiwat Tansirisithikul, Inthira Khumpalikit, S. Nunta-aree","doi":"10.1055/s-0044-1787051","DOIUrl":"https://doi.org/10.1055/s-0044-1787051","url":null,"abstract":"Abstract Introduction  Differentiation between glioblastoma (GBM), primary central nervous system lymphoma (PCNSL), and metastasis is important in decision-making before surgery. However, these malignant brain tumors have overlapping features. This study aimed to identify predictors differentiating between GBM, PCNSL, and metastasis. Materials and Methods  Patients with a solitary intracranial enhancing tumor and a histopathological diagnosis of GBM, PCNSL, or metastasis were investigated. All patients with intracranial lymphoma had PCNSL without extracranial involvement. Demographic, clinical, and radiographic data were analyzed to determine their associations with the tumor types. Results  The predictors associated with GBM were functional impairment ( p  = 0.001), large tumor size ( p  < 0.001), irregular tumor margin ( p  < 0.001), heterogeneous contrast enhancement ( p  < 0.001), central necrosis ( p  < 0.001), intratumoral hemorrhage ( p  = 0.018), abnormal flow void ( p  < 0.001), and hypodensity component on noncontrast cranial computed tomography (CT) scan ( p  < 0.001). The predictors associated with PCNSL comprised functional impairment ( p  = 0.005), deep-seated tumor location ( p  = 0.006), homogeneous contrast enhancement ( p  < 0.001), absence of cystic appearance ( p  = 0.008), presence of hypointensity component on precontrast cranial T1-weighted magnetic resonance imaging (MRI; p  = 0.027), and presence of isodensity component on noncontrast cranial CT ( p  < 0.008). Finally, the predictors for metastasis were an infratentorial ( p  < 0.001) or extra-axial tumor location ( p  = 0.035), smooth tumor margin ( p  < 0.001), and presence of isointensity component on cranial fluid-attenuated inversion recovery MRI ( p  = 0.047). Conclusion  These predictors may be used to differentiate between GBM, PCNSL, and metastasis, and they are useful in clinical management.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141377920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telemedicine in Follow-up after Spine Surgery: Need of the Hour 脊柱手术后随访中的远程医疗:当务之急
Pub Date : 2024-06-06 DOI: 10.1055/s-0044-1787082
Pankaj Totala, Vikas Janu, R. Sharma, Mohit Agrawal, M. Garg, J. Gosal, S. Bhaskar, D. Jha
Abstract Purpose  There is an acute shortage of neurosurgeons and spine surgeons especially in rural areas of low- and middle-income countries including India. Patients of spine surgery need to travel long distances for follow-up at tertiary care hospitals. This study was done to evaluate role and success rate of telemedicine in follow-up after spine surgery based on patients' diagnosis and demographic features and to identify barriers to successful telemedicine consultations. Methods  All patients undergoing spine surgeries including craniovertebral junction (CVJ) surgeries from January 2021 to June 2022 were included in the study. Success rate of telemedicine was calculated using a simple formula: Success rate of telemedicine = successful telemedicine consultations / total number of telemedicine consultation × 100. Success rate was evaluated with respect to demographic features and underlying disease-related factors. Results  Eighty-four patients formed the study group in which a total of 181 video teleconsultations were done. Overall success rate of telemedicine was 82.87%. Higher socioeconomic and educational statuses were related to higher success rates of tele-consultations ( p  < 0.05). Difficulty in assessing neurological condition using video call in follow-up cases of CVJ and issues related to Internet communication network leading to inability to video call and share image/videos were major causes of failures. Conclusion  Telemedicine may prove an effective option for following up patients undergoing spine surgeries except CVJ, which is likely to improve further with improvements in Internet connectivity.
摘要 目的 神经外科医生和脊柱外科医生严重短缺,尤其是在包括印度在内的中低收入国家的农村地区。脊柱手术患者需要长途跋涉到三级医院接受随访。本研究旨在根据患者的诊断和人口统计学特征,评估远程医疗在脊柱手术后随访中的作用和成功率,并找出成功进行远程医疗会诊的障碍。方法 将 2021 年 1 月至 2022 年 6 月期间接受脊柱手术(包括颅椎体交界处(CVJ)手术)的所有患者纳入研究。远程医疗的成功率用一个简单的公式计算:远程医疗成功率 = 远程医疗会诊成功率/远程医疗会诊总数 × 100。成功率的评估与人口统计学特征和基础疾病相关因素有关。结果 84 名患者组成了研究小组,共进行了 181 次视频远程会诊。远程医疗的总体成功率为 82.87%。较高的社会经济地位和教育程度与较高的远程会诊成功率有关(P < 0.05)。在 CVJ 随访病例中使用视频通话评估神经系统状况存在困难,以及与互联网通信网络相关的问题导致无法进行视频通话和共享图像/视频是失败的主要原因。结论 远程医疗可能被证明是对脊柱手术(CVJ 除外)患者进行随访的有效选择,随着互联网连接的改善,这种选择可能会得到进一步改善。
{"title":"Telemedicine in Follow-up after Spine Surgery: Need of the Hour","authors":"Pankaj Totala, Vikas Janu, R. Sharma, Mohit Agrawal, M. Garg, J. Gosal, S. Bhaskar, D. Jha","doi":"10.1055/s-0044-1787082","DOIUrl":"https://doi.org/10.1055/s-0044-1787082","url":null,"abstract":"Abstract Purpose  There is an acute shortage of neurosurgeons and spine surgeons especially in rural areas of low- and middle-income countries including India. Patients of spine surgery need to travel long distances for follow-up at tertiary care hospitals. This study was done to evaluate role and success rate of telemedicine in follow-up after spine surgery based on patients' diagnosis and demographic features and to identify barriers to successful telemedicine consultations. Methods  All patients undergoing spine surgeries including craniovertebral junction (CVJ) surgeries from January 2021 to June 2022 were included in the study. Success rate of telemedicine was calculated using a simple formula: Success rate of telemedicine = successful telemedicine consultations / total number of telemedicine consultation × 100. Success rate was evaluated with respect to demographic features and underlying disease-related factors. Results  Eighty-four patients formed the study group in which a total of 181 video teleconsultations were done. Overall success rate of telemedicine was 82.87%. Higher socioeconomic and educational statuses were related to higher success rates of tele-consultations ( p  < 0.05). Difficulty in assessing neurological condition using video call in follow-up cases of CVJ and issues related to Internet communication network leading to inability to video call and share image/videos were major causes of failures. Conclusion  Telemedicine may prove an effective option for following up patients undergoing spine surgeries except CVJ, which is likely to improve further with improvements in Internet connectivity.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141376569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variability of Resting Carbon Dioxide Tension in Patients with Intracranial Steno-occlusive Disease 颅内狭窄闭塞症患者静息二氧化碳张力的变异性
Pub Date : 2024-06-06 DOI: 10.1055/s-0044-1786699
Eric Plitman, L. Venkatraghavan, Sanket Agrawal, Vishvak Raghavan, Tumul Chowdhury, O. Sobczyk, E. Sayin, J. Poublanc, James Duffin, David D. Mikulis, J. Fisher
Abstract Introduction  Controlling the partial pressure of carbon dioxide (PaCO 2 ) is an important consideration in patients with intracranial steno-occlusive disease to avoid reductions in critical perfusion from vasoconstriction due to hypocapnia, or reductions in blood flow due to steal physiology during hypercapnia. However, the normal range for resting PCO 2 in this patient population is not known. Therefore, we investigated the variability in resting end-tidal PCO 2 (P ET CO 2 ) in patients with intracranial steno-occlusive disease and the impact of revascularization on resting P ET CO 2 in these patients. Setting and Design  Tertiary care center, retrospective chart review Materials and   Methods We collected resting P ET CO 2 values in adult patients with intracranial steno-occlusive disease who presented to our institution between January 2010 and June 2021. We also explored postrevascularization changes in resting P ET CO 2 in a subset of patients. Results  Two hundred and twenty-seven patients were included [moyamoya vasculopathy ( n  = 98) and intracranial atherosclerotic disease ( n  = 129)]. In the whole cohort, mean ± standard deviation resting P ET CO 2 was 37.8 ± 3.9 mm Hg (range: 26–47). In patients with moyamoya vasculopathy and intracranial atherosclerotic disease, resting P ET CO 2 was 38.4 ± 3.6 mm Hg (range: 28–47) and 37.4 ± 4.1 mm Hg (range: 26–46), respectively. A trend was identified suggesting increasing resting P ET CO 2 after revascularization in patients with low preoperative resting P ET CO 2 (<38 mm Hg) and decreasing resting P ET CO 2 after revascularization in patients with high preoperative resting P ET CO 2 (>38 mm Hg). Conclusions  This study demonstrates that resting P ET CO 2 in patients with intracranial steno-occlusive disease is highly variable. In some patients, there was a change in resting P ET CO 2 after a revascularization procedure.
摘要 引言 控制二氧化碳分压(PaCO 2)是颅内狭窄性闭塞症患者的一个重要考虑因素,以避免因低碳酸血症导致血管收缩而导致临界灌注量减少,或因高碳酸血症期间的盗血生理现象而导致血流量减少。然而,这类患者静息 PCO 2 的正常范围尚不清楚。因此,我们研究了颅内狭窄闭塞症患者静息潮气末 PCO 2(P ET CO 2)的变异性,以及血管再通术对这些患者静息 P ET CO 2 的影响。材料和方法 我们收集了 2010 年 1 月至 2021 年 6 月期间在我院就诊的颅内狭窄闭塞症成年患者的静息 P ET CO 2 值。我们还研究了一部分患者血管重建后静息 P ET CO 2 的变化。结果 共纳入 227 名患者[莫亚莫亚血管病(98 人)和颅内动脉粥样硬化性疾病(129 人)]。在所有患者中,静息 P ET CO 2 的平均值(± 标准差)为 37.8 ± 3.9 mm Hg(范围:26-47)。在患有莫亚莫亚血管病和颅内动脉粥样硬化疾病的患者中,静息 P ET CO 2 分别为 38.4 ± 3.6 mm Hg(范围:28-47)和 37.4 ± 4.1 mm Hg(范围:26-46)。研究发现,术前静息 P ET CO 2 较低(38 毫米汞柱)的患者在血管再通后静息 P ET CO 2 呈上升趋势。结论 本研究表明,颅内狭窄闭塞症患者的静息 P ET CO 2 变化很大。在一些患者中,血管重建术后静息 P ET CO 2 发生了变化。
{"title":"Variability of Resting Carbon Dioxide Tension in Patients with Intracranial Steno-occlusive Disease","authors":"Eric Plitman, L. Venkatraghavan, Sanket Agrawal, Vishvak Raghavan, Tumul Chowdhury, O. Sobczyk, E. Sayin, J. Poublanc, James Duffin, David D. Mikulis, J. Fisher","doi":"10.1055/s-0044-1786699","DOIUrl":"https://doi.org/10.1055/s-0044-1786699","url":null,"abstract":"Abstract Introduction  Controlling the partial pressure of carbon dioxide (PaCO 2 ) is an important consideration in patients with intracranial steno-occlusive disease to avoid reductions in critical perfusion from vasoconstriction due to hypocapnia, or reductions in blood flow due to steal physiology during hypercapnia. However, the normal range for resting PCO 2 in this patient population is not known. Therefore, we investigated the variability in resting end-tidal PCO 2 (P ET CO 2 ) in patients with intracranial steno-occlusive disease and the impact of revascularization on resting P ET CO 2 in these patients. Setting and Design  Tertiary care center, retrospective chart review Materials and   Methods We collected resting P ET CO 2 values in adult patients with intracranial steno-occlusive disease who presented to our institution between January 2010 and June 2021. We also explored postrevascularization changes in resting P ET CO 2 in a subset of patients. Results  Two hundred and twenty-seven patients were included [moyamoya vasculopathy ( n  = 98) and intracranial atherosclerotic disease ( n  = 129)]. In the whole cohort, mean ± standard deviation resting P ET CO 2 was 37.8 ± 3.9 mm Hg (range: 26–47). In patients with moyamoya vasculopathy and intracranial atherosclerotic disease, resting P ET CO 2 was 38.4 ± 3.6 mm Hg (range: 28–47) and 37.4 ± 4.1 mm Hg (range: 26–46), respectively. A trend was identified suggesting increasing resting P ET CO 2 after revascularization in patients with low preoperative resting P ET CO 2 (<38 mm Hg) and decreasing resting P ET CO 2 after revascularization in patients with high preoperative resting P ET CO 2 (>38 mm Hg). Conclusions  This study demonstrates that resting P ET CO 2 in patients with intracranial steno-occlusive disease is highly variable. In some patients, there was a change in resting P ET CO 2 after a revascularization procedure.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141380966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extramedullary Intracranial Plasmacytomas: A Systematic Review of Literature 髓外颅内浆细胞瘤:文献系统回顾
Pub Date : 2024-06-06 DOI: 10.1055/s-0044-1787535
Lucca B. Palavani, Atharva Bapat, Sávio Batista, João Pedro Mendes, L. Oliveira, Raphael Bertani
Abstract Extramedullary plasmacytoma (EMP) is an uncommon disorder characterized by the development of abnormal plasma cell tumors outside the bone marrow. These tumors are typically observed in various locations, including the upper respiratory tract, gastrointestinal tract, and other soft tissues. Among the less explored manifestations of EMP is intracranial EMP, which remains poorly understood due to the limited literature available on the subject. The objective was to comprehend the population characteristics, localization, type, treatment, and outcomes of intracranial EMP. A systematic review of the literature for EMPs was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. The strategy “extramedullary plasmacytoma AND multiple myeloma” was used for the search. The search terms were queried using PubMed, Embase, Scopus, Cochrane, and Web of Science databases. We included only those studies that presented clinical studies with patients diagnosed with intracranial plasmacytomas. In this study, a total of 84 patients from 25 studies were analyzed. The average age of diagnosis was 57.25 years, with a slightly higher proportion of females (57%) compared to male patients (43%). The most common locations of intracranial plasmacytomas were the clivus (29.7%), frontal lobe (18.9%), parietal lobe (8.1%), occipital lobe (6.7%), temporal lobe (6.7%), and sphenoid (4%). Chordoma and meningioma were the most common differential diagnoses encountered during clinical investigations. Treatment modalities included radiotherapy (RT), chemotherapy (QT), surgical resection (SR), and conservative approaches. The most frequent treatment combinations were SR + RT (19%) and RT only (17.8%). Mortality was reported in 48% of the cases, with complete resolution observed in 10 cases and partial resolution in 3 cases. The average follow-up duration was 37.5 months. The clivus is the most frequently reported site of extramedullary intracranial plasmacytoma (EMIP) occurrence, representing 29.7% of cases. Chordomas were commonly observed alongside EMIPs and emerged as the primary differential diagnosis. RT was the predominant treatment modality, with SR considered when feasible. RT alone demonstrated the highest effectiveness in managing EMIPs (30%), while QT as a sole intervention showed lower efficacy. However, a combination of dexamethasone, lenalidomide, and targeted RT displayed promising results, offering improved tumor response and increased safety.
摘要 髓外浆细胞瘤(EMP)是一种不常见的疾病,其特点是在骨髓外出现异常浆细胞肿瘤。这些肿瘤通常发生在不同部位,包括上呼吸道、胃肠道和其他软组织。颅内 EMP 是较少被探讨的 EMP 表现形式之一,由于相关文献有限,人们对其了解仍然较少。本研究旨在了解颅内 EMP 的人群特征、定位、类型、治疗和结果。根据《系统综述和元分析首选报告项目》指南,对 EMPs 文献进行了系统综述。检索策略为 "髓外浆细胞瘤和多发性骨髓瘤"。检索词通过 PubMed、Embase、Scopus、Cochrane 和 Web of Science 数据库进行查询。我们只收录了那些对确诊为颅内浆细胞瘤患者进行临床研究的研究。本研究共分析了 25 项研究中的 84 名患者。确诊患者的平均年龄为 57.25 岁,女性比例(57%)略高于男性(43%)。颅内浆细胞瘤最常见的部位是蝶窦(29.7%)、额叶(18.9%)、顶叶(8.1%)、枕叶(6.7%)、颞叶(6.7%)和蝶窦(4%)。脊索瘤和脑膜瘤是临床检查中最常见的鉴别诊断。治疗方式包括放疗(RT)、化疗(QT)、手术切除(SR)和保守治疗。最常见的治疗组合是SR+RT(19%)和仅RT(17.8%)。据报告,48%的病例出现死亡,10例完全缓解,3例部分缓解。平均随访时间为 37.5 个月。颅骨是髓外颅内浆细胞瘤(EMIP)最常发生的部位,占病例总数的29.7%。脊索瘤通常与颅内浆细胞瘤同时出现,并成为主要的鉴别诊断依据。RT是最主要的治疗方式,在可行的情况下可考虑SR。单用RT治疗EMIP的疗效最高(30%),而单用QT治疗的疗效较低。不过,地塞米松、来那度胺和靶向 RT 的联合治疗效果很好,既改善了肿瘤反应,又提高了安全性。
{"title":"Extramedullary Intracranial Plasmacytomas: A Systematic Review of Literature","authors":"Lucca B. Palavani, Atharva Bapat, Sávio Batista, João Pedro Mendes, L. Oliveira, Raphael Bertani","doi":"10.1055/s-0044-1787535","DOIUrl":"https://doi.org/10.1055/s-0044-1787535","url":null,"abstract":"Abstract Extramedullary plasmacytoma (EMP) is an uncommon disorder characterized by the development of abnormal plasma cell tumors outside the bone marrow. These tumors are typically observed in various locations, including the upper respiratory tract, gastrointestinal tract, and other soft tissues. Among the less explored manifestations of EMP is intracranial EMP, which remains poorly understood due to the limited literature available on the subject. The objective was to comprehend the population characteristics, localization, type, treatment, and outcomes of intracranial EMP. A systematic review of the literature for EMPs was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. The strategy “extramedullary plasmacytoma AND multiple myeloma” was used for the search. The search terms were queried using PubMed, Embase, Scopus, Cochrane, and Web of Science databases. We included only those studies that presented clinical studies with patients diagnosed with intracranial plasmacytomas. In this study, a total of 84 patients from 25 studies were analyzed. The average age of diagnosis was 57.25 years, with a slightly higher proportion of females (57%) compared to male patients (43%). The most common locations of intracranial plasmacytomas were the clivus (29.7%), frontal lobe (18.9%), parietal lobe (8.1%), occipital lobe (6.7%), temporal lobe (6.7%), and sphenoid (4%). Chordoma and meningioma were the most common differential diagnoses encountered during clinical investigations. Treatment modalities included radiotherapy (RT), chemotherapy (QT), surgical resection (SR), and conservative approaches. The most frequent treatment combinations were SR + RT (19%) and RT only (17.8%). Mortality was reported in 48% of the cases, with complete resolution observed in 10 cases and partial resolution in 3 cases. The average follow-up duration was 37.5 months. The clivus is the most frequently reported site of extramedullary intracranial plasmacytoma (EMIP) occurrence, representing 29.7% of cases. Chordomas were commonly observed alongside EMIPs and emerged as the primary differential diagnosis. RT was the predominant treatment modality, with SR considered when feasible. RT alone demonstrated the highest effectiveness in managing EMIPs (30%), while QT as a sole intervention showed lower efficacy. However, a combination of dexamethasone, lenalidomide, and targeted RT displayed promising results, offering improved tumor response and increased safety.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141380551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sumatriptan for Postcraniotomy Headache after Minimally Invasive Craniotomy for Clipping of Aneurysms: A Prospective Randomized Controlled Trial 舒马曲普坦治疗微创开颅夹动脉瘤术后头痛:前瞻性随机对照试验
Pub Date : 2024-06-06 DOI: 10.1055/s-0044-1786702
L. Venkatraghavan, Evan Shao, K. Nijs, M. Dinsmore, Tumul Chowdhury
Abstract Introduction  Postcraniotomy headaches are often underestimated and undertreaded. This study aimed to identify if postoperative administration of sumatriptan after minimally invasive craniotomy for clipping an unruptured aneurysm could reduce postcraniotomy headache and improve the quality of postoperative recovery. Settings and Design  Tertiary care center, single-center randomized double-blind placebo-controlled trial. Materials and Methods  Patients who complained of postoperative headaches after minimally invasive craniotomy for clipping of unruptured aneurysms were randomized to receive subcutaneous sumatriptan (6 mg) or placebo. The primary outcome was the quality of recovery measured 24 hours after surgery. Secondary outcomes were total opioid use and headache score at 24 hours after surgery. Data were analyzed using a Student's t -test or the chi-square test. Results  Forty patients were randomized to receive sumatriptan ( n  = 19) or placebo ( n  = 21). Both groups had similar demographics, comorbidities, and anesthesia management. The Quality of Recovery 40 score was higher for patients receiving sumatriptan compared to placebo, however, not statistically significant (173 [156–196] vs. 148 [139–181], p  = 0.055). Postoperative opioid use between sumatriptan and placebo was lower, but not significant (5.4 vs. 5.6 mg morphine equivalent, p  = 0.71). The severity of headache was also not statistically different between the two groups (5 [4–5] vs. 4 [2–5], p  = 0.155). Conclusion  In patients undergoing minimally invasive craniotomies for aneurysm clipping, sumatriptan given postoperatively has a nonsignificant trend for a higher quality of recovery. Similarly, there was a nonsignificant trend toward lower postcraniotomy headache scores and opioid scores for the patient given sumatriptan.
摘要 引言 开颅术后头痛往往被低估和忽视。本研究旨在确定微创开颅手术切除未破裂动脉瘤后术后服用舒马曲普坦能否减轻开颅术后头痛并改善术后恢复质量。设置与设计 三级医疗中心,单中心随机双盲安慰剂对照试验。材料与方法 在微创开颅手术切除未破裂动脉瘤后抱怨术后头痛的患者随机接受皮下注射舒马曲坦(6 毫克)或安慰剂。主要结果是术后 24 小时的恢复质量。次要结果是术后 24 小时的阿片类药物总用量和头痛评分。数据分析采用学生 t 检验或卡方检验。结果 40 名患者随机接受舒马曲坦(19 人)或安慰剂(21 人)治疗。两组患者的人口统计学、合并症和麻醉管理相似。与安慰剂相比,接受舒马曲普坦治疗的患者恢复质量 40 分更高,但无统计学意义(173 [156-196] vs. 148 [139-181],P = 0.055)。舒马曲普坦和安慰剂的术后阿片类药物用量较低,但无显著性差异(5.4 对 5.6 毫克吗啡当量,P = 0.71)。两组患者的头痛严重程度也没有统计学差异(5 [4-5] 对 4 [2-5],P = 0.155)。结论 在接受微创开颅手术切除动脉瘤的患者中,术后服用舒马曲普坦有提高康复质量的非显著趋势。同样,给予舒马曲普坦的患者开颅术后头痛评分和阿片类药物评分也呈非显著性降低趋势。
{"title":"Sumatriptan for Postcraniotomy Headache after Minimally Invasive Craniotomy for Clipping of Aneurysms: A Prospective Randomized Controlled Trial","authors":"L. Venkatraghavan, Evan Shao, K. Nijs, M. Dinsmore, Tumul Chowdhury","doi":"10.1055/s-0044-1786702","DOIUrl":"https://doi.org/10.1055/s-0044-1786702","url":null,"abstract":"Abstract Introduction  Postcraniotomy headaches are often underestimated and undertreaded. This study aimed to identify if postoperative administration of sumatriptan after minimally invasive craniotomy for clipping an unruptured aneurysm could reduce postcraniotomy headache and improve the quality of postoperative recovery. Settings and Design  Tertiary care center, single-center randomized double-blind placebo-controlled trial. Materials and Methods  Patients who complained of postoperative headaches after minimally invasive craniotomy for clipping of unruptured aneurysms were randomized to receive subcutaneous sumatriptan (6 mg) or placebo. The primary outcome was the quality of recovery measured 24 hours after surgery. Secondary outcomes were total opioid use and headache score at 24 hours after surgery. Data were analyzed using a Student's t -test or the chi-square test. Results  Forty patients were randomized to receive sumatriptan ( n  = 19) or placebo ( n  = 21). Both groups had similar demographics, comorbidities, and anesthesia management. The Quality of Recovery 40 score was higher for patients receiving sumatriptan compared to placebo, however, not statistically significant (173 [156–196] vs. 148 [139–181], p  = 0.055). Postoperative opioid use between sumatriptan and placebo was lower, but not significant (5.4 vs. 5.6 mg morphine equivalent, p  = 0.71). The severity of headache was also not statistically different between the two groups (5 [4–5] vs. 4 [2–5], p  = 0.155). Conclusion  In patients undergoing minimally invasive craniotomies for aneurysm clipping, sumatriptan given postoperatively has a nonsignificant trend for a higher quality of recovery. Similarly, there was a nonsignificant trend toward lower postcraniotomy headache scores and opioid scores for the patient given sumatriptan.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141379402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood Flow Capacity Assessment of End-to-Side Arterial Anastomosis In Vivo in Rats 大鼠体内端侧动脉吻合的血流容量评估
Pub Date : 2024-06-06 DOI: 10.1055/s-0044-1786689
M. S. Staroverov, Vladimir Victorovich Krylov, V. A. Lukyanchikov, Egor Andreevich Orlov, Alexey Alexandrovich Veselkov, Sergey Segreevich Dydykin, Vladislav Dmitrievich Shatdler
Abstract Introduction  The aim of this article was to assess the flow capacity of end-to-side arterial anastomosis depending on the method of its implementation. Materials and Methods  The study was conducted on 30 live Wistar rats in vivo, which were randomly divided into three groups. In each group of animals, an end-to-side microanastamosis was performed using three methods of donor artery preparation: 45 degrees (group A), 90 degrees (group B), and arteriotomy according to the “fish mouth” type (group C). The determination of flow capacity of anastomosis by measuring the blood volume flow with transonic flowmeter was performed. Results  The obtained average values after the anastomosis were, respectively, 7.335 mL/s (standard deviation [SD]: 2.0771; min: 4.05; max: 10.85), 7.36 mL/s (SD: 0.836 mi: 6.15; max: 8.75), and 6.37 mL/s (SD: 1.247; min: 5.05; max: 9.05). No statistically significant difference in the blood volume flow velocity between all types of anastomoses was obtained ( p  = 0.251). Conclusion  The flow capacity of end-to-side arterial anastomosis does not depend on the chosen method of anastomosis.
摘要 引言 本文旨在评估端侧动脉吻合术不同实施方法的血流容量。材料和方法 研究对象是 30 只活体 Wistar 大鼠,随机分为三组。每组动物均采用三种供体动脉准备方法进行端侧微吻合术:45度(A组)、90度(B组)和 "鱼嘴 "式动脉切开术(C组)。通过跨音速流量计测量血容量流量,确定吻合口的流量容量。结果 吻合后的平均值分别为 7.335 mL/s(标准差 [SD]:2.0771;最小:4.05;最大:10.85)、7.36 mL/s(SD:0.836 mi:6.15;最大:8.75)和 6.37 mL/s(SD:1.247;最小:5.05;最大:9.05)。所有类型吻合口的血容量流速差异均无统计学意义(P = 0.251)。结论 端侧动脉吻合术的血流容量并不取决于所选择的吻合方法。
{"title":"Blood Flow Capacity Assessment of End-to-Side Arterial Anastomosis In Vivo in Rats","authors":"M. S. Staroverov, Vladimir Victorovich Krylov, V. A. Lukyanchikov, Egor Andreevich Orlov, Alexey Alexandrovich Veselkov, Sergey Segreevich Dydykin, Vladislav Dmitrievich Shatdler","doi":"10.1055/s-0044-1786689","DOIUrl":"https://doi.org/10.1055/s-0044-1786689","url":null,"abstract":"Abstract Introduction  The aim of this article was to assess the flow capacity of end-to-side arterial anastomosis depending on the method of its implementation. Materials and Methods  The study was conducted on 30 live Wistar rats in vivo, which were randomly divided into three groups. In each group of animals, an end-to-side microanastamosis was performed using three methods of donor artery preparation: 45 degrees (group A), 90 degrees (group B), and arteriotomy according to the “fish mouth” type (group C). The determination of flow capacity of anastomosis by measuring the blood volume flow with transonic flowmeter was performed. Results  The obtained average values after the anastomosis were, respectively, 7.335 mL/s (standard deviation [SD]: 2.0771; min: 4.05; max: 10.85), 7.36 mL/s (SD: 0.836 mi: 6.15; max: 8.75), and 6.37 mL/s (SD: 1.247; min: 5.05; max: 9.05). No statistically significant difference in the blood volume flow velocity between all types of anastomoses was obtained ( p  = 0.251). Conclusion  The flow capacity of end-to-side arterial anastomosis does not depend on the chosen method of anastomosis.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141380957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Accuracy of Somatosensory Evoked Potential and Transcranial Motor Evoked Potential in Detection of Neurological Injury in Intradural Extramedullary Spinal Cord Tumor Surgeries: A Short-Term Follow-Up Prospective Interventional Study Experience from Tertiary Care Center of India 体感诱发电位和经颅运动诱发电位在硬膜外脊髓肿瘤手术中检测神经损伤的诊断准确性:印度三级医疗中心的短期随访前瞻性介入研究经验
Pub Date : 2024-06-05 DOI: 10.1055/s-0044-1787052
M. K. Mishra, N. Pandey, Hanjabam Barun Sharma, R. Prasad, Anurag Sahu, Ravi Shekhar Pradhan, Vikrant Yadav
Abstract Objectives  Intraoperative neuromonitoring (IONM) is an acknowledged tool for real-time neuraxis assessment during surgery. Somatosensory evoked potential (SSEP) and transcranial motor evoked potential (MEP) are commonest deployed modalities of IONM. Role of SSEP and MEP in intradural extramedullary spinal cord tumor (IDEMSCT) surgery is not well established. The aim of this study was to evaluate sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of SSEP and transcranial MEP, in detection of intraoperative neurological injury in IDEMSCT patients as well as their postoperative limb-specific neurological improvement assessment at fixed intervals till 30 days. Materials and Methods  Symptomatic patients with IDEMSCTs were selected according to the inclusion criteria of study protocol. On modified McCormick (mMC) scale, their sensory-motor deficit was assessed both preoperatively and postoperatively. Surgery was done under SSEP and MEP (transcranial) monitoring using appropriate anesthetic agents. Gross total/subtotal resection of tumor was achieved as per IONM warning alarms. Sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of SSEP and MEP were calculated considering postoperative neurological changes as “reference standard.” Patients were followed up at postoperative day (POD) 0, 1, 7, and 30 for convalescence. Statistical Analysis  With appropriate tests of significance, statistical analysis was carried out. Receiver-operating characteristic curve was used to find cutoff point of mMC for SSEP being recordable in patients with higher neurological deficit along with calculation of sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of SSEP and MEP for prediction of intraoperative neurological injury. Results  Study included 32 patients. Baseline mean mMC value was 2.59. Under neuromonitoring, gross total resection of IDEMSCT was achieved in 87.5% patients. SSEP was recordable in subset of patients with mMC value less than or equal to 2 with diagnostic accuracy of 100%. MEP was recordable in all patients and it had 96.88% diagnostic accuracy. Statistically significant neurological improvement was noted at POD-7 and POD-30 follow-up. Conclusion  SSEP and MEP individually carry high diagnostic accuracy in detection of intraoperative neurological injuries in patients undergoing IDEMSCT surgery. MEP continues to monitor the neuraxis, even in those subsets of patients where SSEP fails to record.
摘要 目的 术中神经监测(IONM)是公认的在手术过程中对神经轴进行实时评估的工具。躯体感觉诱发电位(SSEP)和经颅运动诱发电位(MEP)是最常见的术中神经监测模式。躯体感觉诱发电位(SSEP)和经颅运动诱发电位(MEP)在硬膜内髓外脊髓肿瘤(IDEMSCT)手术中的作用尚未完全确定。本研究旨在评估 SSEP 和经颅 MEP 在检测 IDEMSCT 患者术中神经损伤方面的敏感性、特异性、阳性预测值、阴性预测值和诊断准确性,以及术后 30 天内固定间隔的肢体特异性神经改善评估。材料和方法 根据研究方案的纳入标准选择有症状的 IDEMSCT 患者。根据改良麦考密克(mMC)量表评估患者术前和术后的感觉运动缺损情况。手术在 SSEP 和 MEP(经颅)监测下进行,并使用适当的麻醉剂。根据 IONM 警报,实现了肿瘤的全/次全切除。将术后神经系统变化作为 "参考标准",计算了 SSEP 和 MEP 的敏感性、特异性、阳性预测值、阴性预测值和诊断准确性。在术后第 0 天、第 1 天、第 7 天和第 30 天对患者进行随访,以了解其恢复情况。统计分析 采用适当的显著性检验进行统计分析。使用接收者操作特征曲线找出 mMC 临界点,以确定在神经功能缺损程度较高的患者中是否可记录 SSEP,同时计算 SSEP 和 MEP 预测术中神经损伤的敏感性、特异性、阳性预测值、阴性预测值和诊断准确性。结果 研究包括 32 名患者。基线平均 mMC 值为 2.59。在神经监测下,87.5% 的患者实现了 IDEMSCT 的全切除。在 mMC 值小于或等于 2 的患者中,可记录 SSEP,诊断准确率为 100%。所有患者均可记录 MEP,诊断准确率为 96.88%。据统计,POD-7 和 POD-30 随访时神经功能明显改善。结论 SSEP 和 MEP 在检测 IDEMSCT 手术患者术中神经损伤方面具有很高的诊断准确性。MEP 可继续监测神经轴,即使在 SSEP 无法记录的患者中也是如此。
{"title":"Diagnostic Accuracy of Somatosensory Evoked Potential and Transcranial Motor Evoked Potential in Detection of Neurological Injury in Intradural Extramedullary Spinal Cord Tumor Surgeries: A Short-Term Follow-Up Prospective Interventional Study Experience from Tertiary Care Center of India","authors":"M. K. Mishra, N. Pandey, Hanjabam Barun Sharma, R. Prasad, Anurag Sahu, Ravi Shekhar Pradhan, Vikrant Yadav","doi":"10.1055/s-0044-1787052","DOIUrl":"https://doi.org/10.1055/s-0044-1787052","url":null,"abstract":"Abstract Objectives  Intraoperative neuromonitoring (IONM) is an acknowledged tool for real-time neuraxis assessment during surgery. Somatosensory evoked potential (SSEP) and transcranial motor evoked potential (MEP) are commonest deployed modalities of IONM. Role of SSEP and MEP in intradural extramedullary spinal cord tumor (IDEMSCT) surgery is not well established. The aim of this study was to evaluate sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of SSEP and transcranial MEP, in detection of intraoperative neurological injury in IDEMSCT patients as well as their postoperative limb-specific neurological improvement assessment at fixed intervals till 30 days. Materials and Methods  Symptomatic patients with IDEMSCTs were selected according to the inclusion criteria of study protocol. On modified McCormick (mMC) scale, their sensory-motor deficit was assessed both preoperatively and postoperatively. Surgery was done under SSEP and MEP (transcranial) monitoring using appropriate anesthetic agents. Gross total/subtotal resection of tumor was achieved as per IONM warning alarms. Sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of SSEP and MEP were calculated considering postoperative neurological changes as “reference standard.” Patients were followed up at postoperative day (POD) 0, 1, 7, and 30 for convalescence. Statistical Analysis  With appropriate tests of significance, statistical analysis was carried out. Receiver-operating characteristic curve was used to find cutoff point of mMC for SSEP being recordable in patients with higher neurological deficit along with calculation of sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of SSEP and MEP for prediction of intraoperative neurological injury. Results  Study included 32 patients. Baseline mean mMC value was 2.59. Under neuromonitoring, gross total resection of IDEMSCT was achieved in 87.5% patients. SSEP was recordable in subset of patients with mMC value less than or equal to 2 with diagnostic accuracy of 100%. MEP was recordable in all patients and it had 96.88% diagnostic accuracy. Statistically significant neurological improvement was noted at POD-7 and POD-30 follow-up. Conclusion  SSEP and MEP individually carry high diagnostic accuracy in detection of intraoperative neurological injuries in patients undergoing IDEMSCT surgery. MEP continues to monitor the neuraxis, even in those subsets of patients where SSEP fails to record.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141382983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suturing and Closure of Diaphragma Sella to Augment Sellar Floor Repair after Endonasal Endoscopic Resection of Large Pituitary Adenoma 鼻内镜下切除巨大垂体腺瘤后缝合膈肌以增强泽兰底修补术
Pub Date : 2024-06-05 DOI: 10.1055/s-0044-1787088
Sushant K. Sahoo, Murali K. Bethanbhatla, S. Dhandapani
Abstract Background  Large pituitary adenoma often pushes the diaphragma sella and extends to the suprasellar compartment. The thinned out diaphragma may get opened during endonasal endoscopic surgery and pose high risk for cerebrospinal fluid (CSF) leak. Such larger defects are difficult to plug with fat graft that tends to slip in to the subarachnoid space. Here, we describe a unique technique of closure of diaphragma sella that augment repair of the skull base in such cases. Method  The free edge of diaphragma sella was sutured with the anterior tuberculum sella dura in five cases of large pituitary adenoma that needed extra arachnoidal resection. Suturing was done with 6-0 prolene using endoscopic needle holder that converted a large diaphragm defect in to a smaller arachnoid rent and was easily plugged with fat graft. Result  None of these patients had postoperative CSF leak. Conclusion  Though technically difficult, direct repair of the diaphragma sella is possible. This augments the skull base reconstruct and effectively reduces the chances of postoperative CSF leak.
摘要 背景 大型垂体腺瘤通常会压迫蝶鞍膈,并延伸至鞍上区。在进行鼻内镜手术时,变薄的膈肌可能会被打开,造成脑脊液(CSF)漏的高风险。这种较大的缺损很难用脂肪移植堵塞,因为脂肪移植往往会滑入蛛网膜下腔。在此,我们介绍一种独特的蝶鞍膈闭合技术,该技术可增强此类病例的颅底修复。方法 在五例需要额外蛛网膜切除的巨大垂体腺瘤病例中,将蝶鞍膈游离缘与硬脑膜前结节缝合。使用内窥镜持针器,用 6-0 prolene 进行缝合,将大的膈肌缺损转化为较小的蛛网膜裂隙,并很容易用脂肪移植堵塞。结果 这些患者术后均无 CSF 渗漏。结论 尽管技术上有难度,但直接修复颅膈是可行的。这可以增强颅底重建,有效降低术后 CSF 渗漏的几率。
{"title":"Suturing and Closure of Diaphragma Sella to Augment Sellar Floor Repair after Endonasal Endoscopic Resection of Large Pituitary Adenoma","authors":"Sushant K. Sahoo, Murali K. Bethanbhatla, S. Dhandapani","doi":"10.1055/s-0044-1787088","DOIUrl":"https://doi.org/10.1055/s-0044-1787088","url":null,"abstract":"Abstract Background  Large pituitary adenoma often pushes the diaphragma sella and extends to the suprasellar compartment. The thinned out diaphragma may get opened during endonasal endoscopic surgery and pose high risk for cerebrospinal fluid (CSF) leak. Such larger defects are difficult to plug with fat graft that tends to slip in to the subarachnoid space. Here, we describe a unique technique of closure of diaphragma sella that augment repair of the skull base in such cases. Method  The free edge of diaphragma sella was sutured with the anterior tuberculum sella dura in five cases of large pituitary adenoma that needed extra arachnoidal resection. Suturing was done with 6-0 prolene using endoscopic needle holder that converted a large diaphragm defect in to a smaller arachnoid rent and was easily plugged with fat graft. Result  None of these patients had postoperative CSF leak. Conclusion  Though technically difficult, direct repair of the diaphragma sella is possible. This augments the skull base reconstruct and effectively reduces the chances of postoperative CSF leak.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141385732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asian Journal of Neurosurgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1